Recombinant Human PNLIP/Pancreatic lipase Protein，His

PLA2G2E, or phospholipase A2 group IIE, is an important enzyme involved in various physiological processes, including inflammation, cell signaling, and membrane dynamics. As a member of the phospholipase A2 family, it catalyzes the hydrolysis of phospholipids, resulting in the release of arachidonic acid and lysophospholipids, which serve as precursors for bioactive lipid mediators. The enzyme's role in inflammatory responses and its potential involvement in various diseases, such as cancer and autoimmune disorders, have garnered significant interest from researchers. Studies have shown that PLA2G2E expression can be regulated by pro-inflammatory cytokines and is implicated in the pathogenesis of chronic inflammatory conditions. Furthermore, recombinant PLA2G2E protein has become a valuable tool for investigating its biochemical properties, substrate specificity, and regulatory mechanisms. The production of this protein through recombinant DNA technology enables detailed studies into its structure-function relationships and interactions with other cellular components. Understanding PLA2G2E's role in disease processes may also unveil potential therapeutic targets for modulating inflammation and other related conditions, making it a focal point in molecular biology and pharmacology research. As a result, ongoing studies aim to elucidate the biological significance of PLA2G2E, paving the way for innovative strategies in disease management and treatment.